Inventor
Aaron N. Nguyen
Inventor
San Jose, CA, US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes35%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms15%
PatentTitleYear
10,849,898Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomas202010,548,896Treatment of relapsed and/or refractory solid tumors and non-Hodgkin's lymphomas202010,543,213Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas202010,328,077Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomas20199,693,987'Methods for treating cancers using oral formulations of cytidine analogs'20179,125,884'Methods for treating cancers using oral formulations of cytidine analogs'20159,101,579'Inhibition of drug resistant cancer cells'20158,841,277'Methods for treating non-small cell lung cancer using 5-azacytidine'20148,492,361'Methods for treating non-small cell lung cancer using 5-azacytidine'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2019Patents assigned to CELGENE CORP (6)· patent assignee history
2013Patents assigned to MACBETH KYLE J (1)· patent assignee history
2013Patents assigned to NGUYEN AARON N (1)· patent assignee history
2013–2020Based in San Jose, CA, US· patent location history
2020Patents assigned to CELGENE QUANTICEL RES INC (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CELGENE CORP | 6 | 2013–2019 |
| CELGENE QUANTICEL RES INC | 3 | 2020 |
| MACBETH KYLE J | 1 | 2013 |
| NGUYEN AARON Nself | 1 | 2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Jose, California, US | 9 | 2013–2020 |